Cardiovascular Interventions Related Topics 
Circulation: Cardiovascular Interventions
MARCH 9, 2025
Circulation: Cardiovascular Interventions, Ahead of Print. Background:Nickel-containing devices, such as the Amplatzer PFO Occluder and Gore Cardioform Septal Occluder (GSO), are used for transcatheter patent foramen ovale (PFO) closure.
Circulation
FEBRUARY 13, 2025
Over the past decade, the cardiac intensive care unit has continued to transform with an aging population, increased clinical acuity, burgeoning cardiac and noncardiac comorbidities, technologic advances in cardiovascular interventions, and increased use of temporary mechanical circulatory support devices.
American College of Cardiology
FEBRUARY 20, 2025
19 in JACC: Cardiovascular Interventions. SGLT2 inhibitors may slow the progression of nonsevere aortic stenosis (AS), according to a study published Feb.
DAIC
APRIL 5, 2024
The acquisition of Shockwave further extends Johnson & Johnson MedTech’s position in cardiovascular intervention and accelerates its shift into higher-growth markets. Cardiovascular intervention is one of the fastest-growing global medtech markets, with significant unmet patient need.
DAIC
MAY 31, 2024
This transaction further extends Johnson & Johnson MedTech’s leadership in cardiovascular intervention. We are excited to begin collaborating directly with the Shockwave team and look forward to a bright future together.”
DAIC
APRIL 12, 2024
Getty Images milla1cf Fri, 04/12/2024 - 20:55 April 12, 2024 — Simpson Interventions, Inc. , Food and Drug Administration ( FDA ).
American College of Cardiology
MARCH 12, 2025
A State-of-the-Art Review published March 10 in JACC: Cardiovascular Interventions highlights a proposed treatment algorithm for the endovascular revascularization of femoropopliteal lesions and chronic total occlusions.
Expert insights. Personalized for you.
70 
Let's personalize your content